Navigation Links
FDA Clears Medivance's Arctic Sun 5000 for Fastest, Easiest Therapeutic Temperature Management
Date:9/15/2010

LOUISVILLE, Colo., Sept. 15 /PRNewswire/ -- Medivance today announced the introduction of its next-generation therapeutic temperature management device, the non-invasive Arctic Sun® 5000.  The new patient cooling device has received FDA 510 (k) clearance and offers the fastest initiation of treatment, simplest programming capabilities and easiest access to treatment data on the market.

"We beta tested the new device for six months and it's an incredible machine for both therapeutic hypothermia and normothermia indications," said Mary Kay Bader, RN, MSN, CCNS, FAHA of California's Mission Hospital, a nationally renowned cooling expert.  "It's so easy to use and has new functions we find very valuable."

Ms. Bader and others cite the Arctic Sun's pre-programmed protocols and new trend analysis and data collection capabilities as key enhancements that optimize patient care.

"The entire staff loved the Arctic Sun 5000," Bader said.

Favored by hospitals worldwide for its safety, simplicity and precision, the newest Arctic Sun also features:

  • Embedded training
  • The ability to pre-program hospital protocols for rapid induction of temperature control with the push of a button
  • Comprehensive help screen with pop-up explanations for all alerts
  • Voice and visual prompts for added safety
  • Data storage during patient transfers, with ability to "continue current patient case" for up to 6 hours
  • More efficient cooling
  • Touch screen
  • Ability to download up to 10 cases from device memory for research or analysis purposes
  • Automatic initiation of rewarming

"The Arctic Sun 5000 brings precision Targeted Temperature Management™ to the highest level of performance available today," said Medivance CEO Robert Kline.  "With the Arctic Sun 5000 we have made it as effortless as possible to initiate this promising non-invasive therapy that may spare many more critically ill patients from devastating brain damage."

About Medivance's Arctic Sun 5000

The non-invasive Arctic Sun 5000 precisely monitors and maintains core body temperature in a therapeutic range, between 32 and 38.5 degrees Celsius (approximately 89.6 to 101.3 degrees Fahrenheit) with the potential to minimize damage to the heart and brain. The patented design of the Arctic Sun and ArcticGel™ Pads enables them to transfer up to five times more thermal energy than conventional products such as water blankets, wraps or ice packs, resulting in more efficient temperature management. The system's precision also enables the slow rewarming thought to be critical for therapeutic benefit.  The Arctic Sun 5000 has received 510(k) FDA clearance in the U.S. and the European Union's CE Mark.  Medivance develops and manufactures non-invasive, proprietary therapeutic temperature management solutions.   http://www.medivance.com.


'/>"/>
SOURCE Medivance
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Scientist clears hurdles for muscular dystrophy therapy
2. Arctic sea ice thinning at record rate
3. FSU Historians Arctic research has him sitting on top of the world
4. First comprehensive inventory of life in Antarctica
5. ESA satellites focusing on the Arctic
6. Arctic heats up more than other places
7. Global warming threatens Antarctic sea life
8. Marine scientists to assess environment before offshore drilling begins in US arctic waters
9. CO2 drop and global cooling caused Antarctic glacier to form
10. Final frontier: Mission to explore buried ancient Antarctic lake given green light
11. UK robot sub searches for signs of melting 60 km into an Antarctic ice shelf cavity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... PORTLAND, Oregon and PUNE, India , January 12, 2017 ... Technology Market: Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology ... CAGR of 19.4% from 2016 to 2022. Continue Reading ... ... ...
(Date:1/6/2017)... 6, 2017  Privately-held CalciMedica, Inc., announced that ... volunteers of a novel calcium release-activated calcium (CRAC) ... Acute pancreatitis, sudden painful inflammation ... but can be very serious.  In severe cases it ... extended hospital stays, time in the ICU and ...
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... January 20, 2017 Stock-Callers.com explores ... have influenced the most recent performances of select equities. ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... Grand View Research, global Biotech market size is expected to reach $604.40 ...
(Date:1/19/2017)... Jan. 19, 2017  Market Research Future has a half cooked ... Liquid Biopsy is growing rapidly and expected to reach USD 450 ... Highlights ... Liquid Biopsy Market has been assessed as a swiftly growing market ... boom in the coming future. There has been a tremendous growth ...
(Date:1/19/2017)... ... January 19, 2017 , ... November ... to leading biopharmaceutical and medical device manufacturers and regulators, is proud to announce ... Part 11-compliant email client designed to provide product vigilance departments with the flexibility ...
(Date:1/19/2017)... Yorba Linda, Ca (PRWEB) , ... January 18, ... ... interactive virtual events for tech innovators, engineers, and scientists from around the world, ... Corporate American News. The awards program is based entirely on merit and decided ...
Breaking Biology Technology: